Immunology for
a Better Future

Learn More

Our lead program, Ampligen®, is an immuno-modulator that has shown broad spectrum activity in in-vitro and animal testing and is being evaluated in clinical studies for a range of debilitating and life-threatening conditions.

Learn More

We are working to develop solutions that have the potential to help patients across a number of disease areas, including oncology, immune disorders and viral diseases.

Learn More

Advancing Therapeutic
Solutions

Our lead program, Ampligen®, is an immuno-modulator that has shown broad spectrum activity in in-vitro and animal testing and is being evaluated in clinical studies for a range of debilitating and life-threatening conditions.

Learn More

Focused on Improving
Lives

We are working to develop solutions that have the potential to help patients across a number of disease areas, including oncology, immune disorders and viral diseases.

Learn More

Key Highlights

AIM ImmunoTech Announces Launch of CEO Corner Platform

CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties the ability to ask questions and submit topics for future videos Access the AIM CEO Corner Here! OCALA, Fla., March 07, 2024 --...